Researcher.Life Logo

Therapeutic Advances in Chronic Disease : Impact Factor & More

eISSN: 2040-6231pISSN: 2040-6223
JournalOpen Access

Key Metrics

CiteScore
5.4
Impact Factor
< 5
SJR
Q2Medicine (miscellaneous)
SNIP
1.43
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Therapeutic Advances in Chronic Disease

Therapeutic Advances in Chronic Disease Journal Specifications

Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2300
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Therapeutic Advances in Chronic Disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Therapeutic Advances in Chronic Disease

Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study
  • 1 Jan 2026
  • Therapeutic Advances in Chronic Disease
Factors associated with disease knowledge and medication adherence among rheumatoid arthritis patients attending a private rheumatology clinic: A cross-sectional study
  • 1 Jan 2026
  • Therapeutic Advances in Chronic Disease
The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review
  • 1 Nov 2025
  • Therapeutic Advances in Chronic Disease
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
  • 1 Nov 2025
  • Therapeutic Advances in Chronic Disease
Staging and markers in Parkinson’s disease and Lewy body disorders: narrative review
  • 1 Oct 2025
  • Therapeutic Advances in Chronic Disease
Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study
  • 1 Jan 2026
  • Therapeutic Advances in Chronic Disease
Factors associated with disease knowledge and medication adherence among rheumatoid arthritis patients attending a private rheumatology clinic: A cross-sectional study
  • 1 Jan 2026
  • Therapeutic Advances in Chronic Disease
The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review
  • 1 Nov 2025
  • Therapeutic Advances in Chronic Disease
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
  • 1 Nov 2025
  • Therapeutic Advances in Chronic Disease
Staging and markers in Parkinson’s disease and Lewy body disorders: narrative review
  • 1 Oct 2025
  • Therapeutic Advances in Chronic Disease

FAQs on Therapeutic Advances in Chronic Disease